Literature DB >> 3133390

Evaluation of an immunofluorescent-antibody test for rapid identification of Pseudomonas aeruginosa in blood cultures.

G W Counts1, R W Schwartz, B K Ulness, D J Hamilton, M J Rosok, M D Cunningham, M R Tam, R P Darveau.   

Abstract

An immunofluorescent-antibody test was developed for rapid detection of Pseudomonas aeruginosa in blood cultures. The test uses a murine monoclonal antibody specific for all strains of P. aeruginosa. In initial tests, bright uniform immunofluorescence signals were seen when each of the 17 international serotypes, as well as 14 additional isolates of P. aeruginosa, were examined. No immunofluorescent staining was observed when 37 other gram-negative and 15 gram-positive species were studied. In a clinical study, the assay was applied to broth smears of 86 gram-negative bacilli isolated from 74 bacteremic patients and 28 additional clinical isolates of Pseudomonas sp. and other oxidase-positive gram-negative bacilli recovered from various body sites. Smears were made directly from blood cultures which were positive for gram-negative bacilli by Gram staining. Eleven (15%) of 74 patients with gram-negative bacteremia had a positive test for P. aeruginosa. Including the results of these 11 isolates recovered in a prospective study and an additional 10 isolates from a retrospective study, we obtained a sensitivity and specificity of 100% (21 positive specimens and 103 negative specimens, respectively). These preliminary results suggest that this is a useful reagent for rapid presumptive identification of P. aeruginosa in blood cultures. With the immunofluorescent-antibody test, P. aeruginosa could be identified within 1 h of Gram stain evidence of gram-negative bacteremia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3133390      PMCID: PMC266554          DOI: 10.1128/jcm.26.6.1161-1165.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  20 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases.

Authors:  C Singer; M H Kaplan; D Armstrong
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

3.  Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

Authors:  P L Ey; S J Prowse; C R Jenkin
Journal:  Immunochemistry       Date:  1978-07

Review 4.  Quantitative enzyme immunoassay (ELISA) in microbiology.

Authors:  E Engvall
Journal:  Med Biol       Date:  1977-08

5.  Empirical antimicrobial therapy in the neutropenic host.

Authors:  L S Young
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

Review 6.  Blood cultures: issues and controversies.

Authors:  J A Washington; D M Ilstrup
Journal:  Rev Infect Dis       Date:  1986 Sep-Oct

7.  A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.

Authors:  B de Pauw; K Williams; J de Neeff; T Bothof; T de Witte; R Holdrinet; C Haanen
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

8.  Conjugation of antibodies with fluorochromes: modifications to the standard methods.

Authors:  J W Goding
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Imipenem-cilastatin as initial therapy for febrile cancer patients.

Authors:  G P Bodey; M E Alvarez; P G Jones; K V Rolston; L Steelhammer; V Fainstein
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

10.  Monoclonal antibodies against bacterial outer membrane antigens.

Authors:  R E Hancock; L M Mutharia
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

View more
  11 in total

1.  Rapid presumptive identification of gram-negative rods directly from blood cultures by simple enzymatic tests.

Authors:  J L Sepúlveda; C E Stager; J R Davis
Journal:  J Clin Microbiol       Date:  1990-02       Impact factor: 5.948

2.  Effect of delay in processing on lysis-centrifugation blood culture results from marrow transplant patients.

Authors:  D J Hamilton; D Amos; R W Schwartz; C M Dent; G W Counts
Journal:  J Clin Microbiol       Date:  1989-07       Impact factor: 5.948

3.  Epitope mapping of the Pseudomonas aeruginosa major outer membrane porin protein OprF.

Authors:  E G Rawling; N L Martin; R E Hancock
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

4.  Synthetic peptides representing epitopes of outer membrane protein F of Pseudomonas aeruginosa that elicit antibodies reactive with whole cells of heterologous immunotype strains of P. aeruginosa.

Authors:  E E Hughes; L B Gilleland; H E Gilleland
Journal:  Infect Immun       Date:  1992-09       Impact factor: 3.441

5.  Analysis of the Pseudomonas aeruginosa major outer membrane protein OprF by use of truncated OprF derivatives and monoclonal antibodies.

Authors:  R L Finnen; N L Martin; R J Siehnel; W A Woodruff; M Rosok; R E Hancock
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

6.  Dual function of PilS during transcriptional activation of the Pseudomonas aeruginosa pilin subunit gene.

Authors:  J M Boyd; S Lory
Journal:  J Bacteriol       Date:  1996-02       Impact factor: 3.490

7.  Use of synthetic peptides to identify surface-exposed, linear B-cell epitopes within outer membrane protein F of Pseudomonas aeruginosa.

Authors:  H E Gilleland; E E Hughes; L B Gilleland; J M Matthews-Greer; J Staczek
Journal:  Curr Microbiol       Date:  1995-11       Impact factor: 2.188

8.  Clinical evaluation of a direct fluorescent monoclonal antibody test for detection of Pseudomonas aeruginosa in blood cultures.

Authors:  M A Pfaller; M Barrett; F P Koontz; R P Wenzel; M D Cunningham; N Rollins; R P Darveau
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

9.  A chimeric influenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa affords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection.

Authors:  J Staczek; H E Gilleland; L B Gilleland; R N Harty; A García-Sastre; O G Engelhardt; P Palese
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

10.  Identification of Moraxella bovis by using a monoclonal antibody to a lipopolysaccharide epitope.

Authors:  Y Wannemuehler; K Johansen; R Rosenbusch
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.